EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieBeobachtungsstudie

Outcomes of Supra-Annular vs Intra-Annular Self-Expanding Valves in Valve-In-Valve Transcatheter Aortic Valve Replacement

Kuljit Singh, Edward Dababneh, Maria Gabriela Matta, Selvanayagam Niranjan, Ajay Sinhal, Mark Jones, Anthony Camuglia

JACC: Cardiovascular Interventions · 2026

DOI: 10.1016/j.jcin.2026.06.022 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2026. Verfasst von Kuljit Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Gold Coast Health Service, Gold Coast, Queensland, Australia; Department of Medicine, Griffith University School of Medicin…. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Self-expanding valves appear to have superior hemodynamics compared with balloon-expandable valves for valve-in-valve transcatheter aortic valve replacement (ViV-TAVR). OBJECTIVES: This study aimed to compare echocardiographic and clinical outcome data between supra-annular self-expanding valves (SASEVs) and intra-annular self-expanding valves (IASEVs), which in the past has remained limited, raising the need for further evaluation. METHODS: We analyzed ViV-TAVR procedures in the ACOR (Australian Cardiovascular Outcomes Registry). Patients receiving SASEV or IASEV were included. Baseline clinical and echocardiographic characteristics and postprocedure and 12-month outcomes were assessed. Echocardiographic parameters included gradients and left ventricular ejection fraction. Clinical outcomes included major adverse cardiac and cerebrovascular events, defined according to Valve Academic Research Consortium criteria. RESULTS: A total of 683 patients underwent ViV-TAVR: 566 (82.9%) with SASEV and 117 (17.1%) with IASEV. Baseline demographics were similar, although IASEV had higher rates of heart failure and a higher rate of baseline bioprosthetic valve regurgitation. Postprocedure echocardiographic findings were similar in both groups, with comparable mean gradients (14.9 mm Hg vs 13.3 mm Hg; P = 0.070), peak atrioventricular velocities (2.5 m/s vs 2.4 m/s; P = 0.073) and Dimensionless Performance Index (SASEV 0.4 vs IASEV 0.5; P < 0.001). At 12 months, although not statistically significant, there was a numerical trend toward higher major adverse cardiac and cerebrovascular events (11.9% vs 7.1%; P = 0.129) and stroke rates (5.4% vs 1.7%; P = 0.058) in the IASEV group. No significant differences were observed in mortality or bleeding. Findings were consistent after propensity score adjustment and multivariable logistic regression. CONCLUSIONS: Both SASEV and IASEV provide favorable and similar hemodynamic and clinical outcomes following ViV-TAVR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveAortic Valve StenosisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMaleBioprosthesisHemodynamicsProsthesis DesignRecovery of FunctionRegistriesRisk FactorsStroke VolumeTime FactorsTreatment OutcomeVentricular Function, Left

Stichwörter der Autor:innen

AbbottEvolutMedtronicNavitorPorticoViV-TAVR

Autor:innen und Institutionen

  • Department of Cardiology, Gold Coast Health Service, Gold Coast, Queensland, Australia; Department of Medicine, Griffith University School of Medicine, Gold Coast, Queensland, Australia; Department of Medicine, Universi…
  • Department of Cardiology, Gold Coast Health Service, Gold Coast, Queensland, Australia; Department of Medicine, Griffith University School of Medicine, Gold Coast, Queensland, Australia.
  • Department of Cardiology, Gold Coast Health Service, Gold Coast, Queensland, Australia; Department of Medicine, Griffith University School of Medicine, Gold Coast, Queensland, Australia; Department of Medicine, Bond Uni…
  • Department of Cardiology, Flinders Medical Centre, Adelaide, South Australia, Australia.
  • Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, Australia.
  • Department of Cardiology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia; Department of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Zitieren

APA

Singh, K., Dababneh, E., Matta, M. G., Niranjan, S., Sinhal, A., Jones, M., & Camuglia, A. (2026). Outcomes of Supra-Annular vs Intra-Annular Self-Expanding Valves in Valve-In-Valve Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2026.06.022

Vancouver

Singh K, Dababneh E, Matta MG, Niranjan S, Sinhal A, Jones M, et al. Outcomes of Supra-Annular vs Intra-Annular Self-Expanding Valves in Valve-In-Valve Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2026. doi:10.1016/j.jcin.2026.06.022

BibTeX
@article{Singh2026,
  author = {Singh, Kuljit and Dababneh, Edward and Matta, Maria Gabriela and Niranjan, Selvanayagam and Sinhal, Ajay and Jones, Mark and Camuglia, Anthony},
  title = {Outcomes of Supra-Annular vs Intra-Annular Self-Expanding Valves in Valve-In-Valve Transcatheter Aortic Valve Replacement},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1016/j.jcin.2026.06.022}
}
Kostenlos starten →